2004•Medical OncologyRequires access

Serial Monitoring of BCR-ABL Transcripts in Chronic Myelogenous Leukemia (CML) Treated with Imatinib Mesylate

Mats Hardling, Yuan Wei, Lars Palmqvist, Birgitta Swolin, Dick Stockelberg, Bengt G. Gustavsson, Kerstin Ekeland‐Sjöberg, Hans Wadenvik, Anne Ricksten

Open publisher page 13 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Imatinib, Imatinib mesylate, Chronic myelogenous leukemia, Bone marrow, breakpoint cluster region, Medicine, ABL, Philadelphia chromosome

Back to paper search Browse research topics Original source

Serial Monitoring of BCR-ABL Transcripts in Chronic Myelogenous Leukemia (CML) Treated with Imatinib Mesylate — Research Paper | ScholarLens